1. Addressing BBB Heterogeneity: A New Paradigm for Drug Delivery to Brain Tumors
   Jessica I. Griffith et al, 2020, Pharmaceutics CrossRef
2. Myelopathy associated with acute leukemia. Multidisciplinary view on the problem
   A. Yu. Polushin et al, 2021, Russian neurological journal CrossRef
3. Intrathecal methotrexate induced myelopathy, rare yet serious complication: A case report and review of the literature
   Aram H Bidikian et al, 2021, Current Research in Translational Medicine CrossRef
4. Intrathecal cytosine arabinoside-induced progression of chronic methotrexate myelopathy
   L. Mikhelashvili et al, 2021, Neurological Sciences CrossRef
5. Methotrexate-Induced Subacute Combined Degeneration in Acute Lymphoblastic Leukemia with CNS Relapse May Be Reversible
   David Bared Dukenik et al, 2023, Hemato CrossRef
6. Inadvertent intrathecal administration of daunomycin resulting in fatality: Case report and therapeutic considerations
   Sauson Soldozy et al, 2021, eNeurologicalSci CrossRef
7. Intrathecal Methotrexate-Induced Necrotizing Myelopathy: A Case Report and Review of Histologic Features
   Hamza Tariq et al, 2018, Clinical Medicine Insights: Pathology CrossRef
8. Myelopathy associated with intrathecal methotrexate
   Pedro Gustavo Barros Rodrigues et al, 2022, Practical Neurology CrossRef
9. Case of neuromyelitis optica: bilateral sensorineural hearing loss and transverse myelopathy following intrathecal chemotherapy
   Sergio A Castillo-Torres et al, 2020, BMJ Case Reports CrossRef
10. Blood–Brain Barrier in Brain Tumors: Biology and Clinical Relevance
    Francesca Mo et al, 2021, International Journal of Molecular Sciences CrossRef